|
1
|
de Almeida Sassi F, Brunetto AL,
Schwartsmann G, Roesler R and Abujamra AL: Glioma revisited: from
neurogenesis and cancer stem cells to the epigenetic regulation of
niche. J Oncol. 2012:5378612012. View Article : Google Scholar
|
|
2
|
He H, Li MU and Niu CS: The pathological
characteristics of glioma stem cell niches. J Clin Neurosci.
19:121–127. 2012. View Article : Google Scholar
|
|
3
|
Tavazoie M, Van der Veken L, Silva-Vargas
V, et al: A specialized vascular niche for adult neural stem cells.
Cell Stem Cell. 3:279–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Najbauer J, Huszthy PC, Barish ME, et al:
Cellular host responses in gliomas. PLoS One. 7:e351502012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaur B, Khwaja FW, Severson EA, Matheny
SL, Brat DJ and Van Meir EG: Hypoxia and the
hypoxia-inducible-factor pathway in glioma growth and angiogenesis.
Neuro Oncol. 7:134–153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fei XF, Zhang QB, Dong J, et al:
Development of a clinically relevant orthotopic xenograft mouse
model of metastatic lung cancer and glioblastoma through surgical
tumor tissue injection with trocar. J Exp Clin Cancer Res.
29:842010. View Article : Google Scholar
|
|
7
|
Charles NA, Holland EC, Gilbertson R,
Glass R and Kettenmann H: The brain tumor microenvironment. Glia.
60:1169–1180. 2011. View Article : Google Scholar
|
|
8
|
Hoffman RM: Green fluorescent protein
imaging of tumor cells in mice. Lab Animal. 31:34–41.
2002.PubMed/NCBI
|
|
9
|
Farin A, Suzuki SO, Weiker M, Goldman JE,
Bruce JN and Canoll P: Transplanted glioma cells migrate and
proliferate on host brain vasculature: a dynamic analysis. Glia.
53:799–808. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wan Y, Fei XF, Wang ZM, et al: Expression
of miRNA-125b in the new highly invasive glioma stem cell and
progenitor cell line SU3. Chin J Cancer. 31:207–214. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gillespie DL, Whang K, Ragel BT, Flynn JR,
Kelly DA and Jensen RL: Silencing of hypoxia inducible factor-1α by
RNA interference attenuates human glioma cell growth in
vivo. Clin Cancer Res. 13:2441–2448. 2007.
|
|
12
|
Ryan HE, Poloni M, McNulty W, Elson D,
Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible factor-1α
is a positive factor in solid tumor growth. Cancer Res.
60:4010–4015. 2000.
|
|
13
|
Bos R, Van der Groep P, Greijer AE, et al:
Levels of hypoxia-inducible factor-1α independently predict
prognosis in patients with lymph node negative breast carcinoma.
Cancer. 97:1573–1581. 2003.
|
|
14
|
Zhong H, Semenza GL, Simons JW and De
Marzo AM: Up-regulation of hypoxia-inducible factor 1α is an early
event in prostate carcinogenesis. Cancer Detect Prev. 28:88–93.
2004.
|
|
15
|
Birner P, Schindl M, Obermair A, Plank C,
Breitenecker G and Oberhuber G: Overexpression of hypoxia-inducible
factor 1 α is a marker for an unfavorable prognosis in early-stage
invasive cervical cancer. Cancer Res. 60:4693–4696. 2000.
|
|
16
|
Urano N, Fujiwara Y, Doki Y, et al:
Overexpression of hypoxia-inducible factor-1 alpha in gastric
adenocarcinoma. Gastric Cancer. 9:44–49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clottes E: Hypoxia inducible factor 1:
regulation, involvement in carcinogenesis and target for anticancer
therapy. Bull Cancer. 92:119–127. 2005.(In French).
|
|
18
|
Xia Y, Choi HK and Lee K: Recent advances
in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem.
49:24–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lyu MA and Rosenblum MG: The
immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing
SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of
TNF receptor-1. Mol Cancer Ther. 4:1205–1213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ebert LM, Meuter S and Moser B: Homing and
function of human skin γδ T cells and NK cells: relevance for tumor
surveillance. J Immunol. 176:4331–4336. 2006.
|
|
21
|
Warren MA, Shoemaker SF, Shealy DJ, Bshara
W and Ip MM: Tumor necrosis factor deficiency inhibits mammary
tumorigenesis and a tumor necrosis factor neutralizing antibody
decreases mammary tumor growth in neu/erbB2 transgenic mice. Mol
Cancer Ther. 8:2655–2663. 2009. View Article : Google Scholar
|
|
22
|
Yin Y, Chen X and Shu Y: Gene expression
of the invasive phenotype of TNF-α-treated MCF-7 cells. Biomed
Pharmacother. 63:421–428. 2009.
|
|
23
|
Bettinger I, Thanos S and Paulus W:
Microglia promote glioma migration. Acta Neuropathol. 103:351–355.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Markovic DS, Glass R, Synowitz M, Rooijen
Nv and Kettenmann H: Microglia stimulate the invasiveness of glioma
cells by increasing the activity of metalloprotease-2. J
Neuropathol Exp Neurol. 64:754–762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu A, Wei J, Kong LY, et al: Glioma cancer
stem cells induce immunosuppressive macrophages/microglia. Neuro
Oncol. 12:1113–1125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Straussman R, Morikawa T, Shee K, et al:
Tumour micro-environment elicits innate resistance to RAF
inhibitors through HGF secretion. Nature. 487:500–504. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Borovski T, Verhoeff JJC, ten Cate R, et
al: Tumor microvascular supports proliferation and expansion of
glioma-propagating cells. In J Cancer. 125:1222–1230.
2009.PubMed/NCBI
|
|
28
|
Gazdzinski LM and Nieman BJ: Cellular
imaging and texture analysis distinguish differences in cellular
dynamics in mouse brain tumors. Magn Reson Med. May 9–2013.
View Article : Google Scholar
|
